δEF1 represses BMP-2-induced differentiation of C2C12 myoblasts into the osteoblast lineage

Journal of Biomedical Science

Volumn 14, Issue 5, 2007, Pages 663-679

  Yang, Shuang ^a   Zhao, Li ^a   Yang, Juhua ^a   Chai, Dinggeng ^a   Zhang, Ming ^a   Zhang, Jie ^a   Ji, Xiaohui ^b   Zhu, Tianhui ^a  

^a NANKAI UNIVERSITY   (China)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

EF1; AP 1; BMP 2; N and C terminal zinc finger clusters; Osteoblast differentiation

Indexed keywords

ACTIVATING PROTEIN 1; ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN TYPE 1; DELTA EF1 TRANSCRIPTION FACTOR; PROTEIN; SMAD PROTEIN; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; BONE MORPHOGENETIC PROTEIN; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; OSTEOCALCIN; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR RUNX2; TRANSFORMING GROWTH FACTOR BETA; ZEB1 PROTEIN, HUMAN;

ANALYTIC METHOD; ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; DOWN REGULATION; GENE; GENE OVEREXPRESSION; MARKER GENE; MYOBLAST; NONHUMAN; OSTEOBLAST; OSTEOCALCIN GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; CYTOLOGY; DRUG ANTAGONISM; GENETICS; HUMAN; METABOLISM; MOUSE; PROMOTER REGION;

MURINAE;

ANIMALS; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE; CORE BINDING FACTOR ALPHA 1 SUBUNIT; HOMEODOMAIN PROTEINS; HUMANS; MICE; MYOBLASTS; NF-KAPPA B; OSTEOBLASTS; OSTEOCALCIN; OSTEOGENESIS; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; RNA, MESSENGER; TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION FACTORS; TRANSFORMING GROWTH FACTOR BETA; ZINC FINGERS;

EID: 34548695219     PISSN: 10217770     EISSN: 14230127     Source Type: Journal    
DOI: 10.1007/s11373-007-9155-5     Document Type: Article

References (57)

1. Ten Dijke P., Miyazono K., Heldin C.H. (2000) Signaling inputs converge on nuclear effectors in TGF-beta signaling. Trends Biochem. Sci. 25: 64-70
2. Wozney J.M., Rosen V. (1998) Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin. Orthop. Relat. Res. 346: 26-37
3. Franceschi R.T., Xiao G. (2003) Regulation of the osteoblast-specific transcription factor, Runx2: responsiveness to multiple signal transduction pathways. J. Cell. Biochem. 88: 446-454
4. Kim Y.J., Lee M.H., Wozney J.M., Cho J.Y., Ryoo H.M. (2004) Bone morphogenetic protein-2-induced alkaline phosphatase expression is stimulated by Dlx5 and repressed by Msx2. J. Biol. Chem. 279: 50773-50780
5. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29
6. Olney R.C. (2003) Regulation of bone mass by growth hormone. Med. Pediatr. Oncol. 41: 228-234
7. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. (1994) Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 127: 1755-1766
8. Massague J., Wotton D. (2000) Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19: 1745-1754
9. Wrana J.L., Attisano L. (2000) The Smad pathway. Cytokine Growth Factor Rev. 11: 5-13
10. Miyazono K., Kusanagi K., Inoue H. (2001) Divergence and convergence of TGF-β/BMP signaling. J. Cell. Physiol. 187: 265-276
11. Attisano L., Wrana J.L. (2002) Signal transduction by the TGF-ß superfamily. Science 296: 1646-1647
12. Lai C.F., Cheng S.L. (2002) Signal transductions induced by bone morphogenetic protein-2 and transforming growth factor-beta in normal human osteoblastic cells. J. Biol. Chem. 277: 15514-15522
13. Celil A.B., Campbell P.G. (2005) BMP-2 and insulin-like growth factor-I mediate osterix (Osx) expression in human mesenchymal stem cells via the MAPK and protein kinase D signaling pathways. J. Biol. Chem. 280: 31353-31359
14. Naito J., Kaji H., Sowa H., Hendy G.N., Sugimoto T., Chihara K. (2005) Menin Suppresses Osteoblast Differentiation by Antagonizing the AP-1 Factor, JunD. J. Biol. Chem. 280: 4785-4791
15. Palcy S., Goltzman D. (1999) Protein kinase signalling pathways involved in the up-regulation of the rat alpha1(I) collagen gene by transforming growth factor beta1 and bone morphogenetic protein 2 in osteoblastic cells. Biochem. J. 343: 21-27
16. Gallea S., Lallemand F., Atfi A., Rawadi G., Ramez V., Spinella-Jaegle S., Kawai S., Faucheu C., Huet L., Baron R., Roman-Roman S. (2001) Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28: 491-498
17. Lee K.S., Hong S.H., Bae S.C. (2002) Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-beta and bone morphogenetic protein. Oncogene. 21: 7156-7163
18. Celil A.B., Hollinger J.O., Campbell P.G. (2005) Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J. Cell. Biolchem. 95: 518-528
19. Fortini M.E., Lai Z.C., Rubin G.M. (1991) The Drosophila zfh-1 and zfh-2 genes encode novel proteins containing both zinc-finger and homeodomain motifs. Mech. Dev. 34: 113-122
20. Lai Z.C., Rushton E., Bate M., Rubin G.M. (1993) Loss of function of the Drosophila zfh-1 gene results in abnormal development of mesodermally derived tissues. Proc. Natl. Acad. Sci. U.S.A. 90: 4122-4126
21. Verschueren K., Remacle J.E., Collart C., Kraft H., Baker B.S., Tylzanowski P., Nelles L., Wuytens G., Su M.T., Bodmer R., Smith J.C., Huylebroeck D. (1999) SIP1, a novel zinc finger/homeodomain repressor, interacts with Smad proteins and binds to 5′-CACCT sequences in candidate target genes. J. Biol. Chem. 274: 20489-20498
22. Watanabe Y., Kawakami K., Hirayama Y., Nagano K. (1993) Transcription factors positively and negatively regulating the Na,K-ATPase alpha 1 subunit gene. J. Biochem. 114: 849-855
23. Funahashi J., Kamachi Y., Goto K., Kondoh H. (1991) Identification of nuclear factor delta EF1 and its binding site essential for lens-specific activity of the delta 1-crystallin enhancer. Nucleic Acids Res. 19: 3543-3547
24. Funahashi J., Sekido R., Murai K., Kamachi Y., Kondoh H. (1993) Delta-crystallin enhancer binding protein delta EF1 is a zinc finger-homeodomain protein implicated in postgastrulation embryogenesis. Development 119: 433-446
25. Takagi T., Moribe H., Kondoh H., Higashi Y. (1998) DeltaEF1, a zinc finger and homeodomain transcription factor, is required for skeleton patterning in multiple lineages. Development 125: 21-31
26. Sekido R., Takagi T., Okanami M., Moribe H., Yamamura M., Higashi Y., Kondoh H. (1996) Organization of the gene encoding transcriptional repressor deltaEF1 and cross-species conservation of its domains. Gene 173: 227-232
27. Franklin A.J., Jetton T.L., Shelton K.D., Magnuson M.A. (1994) BZP, a novel serum-responsive zinc finger protein that inhibits gene transcription. Mol. Cell. Biol. 14: 6773-6788
28. Kamachi Y., Kondoh H. (1993) Overlapping positive and negative regulatory elements determine lens-specific activity of the delta 1-crystallin enhancer. Mol. Cell. Biol. 13: 5206-5215
29. Sekido R., Murai K., Kamachi Y., Kondoh H. (1997) Two mechanisms in the action of repressor deltaEF1: binding site competition with an activator and active repression. Genes Cells 2: 771-783
30. Sekido R., Murai K., Funahashi J., Kamachi Y., Fujisawa-Sehara A., Nabeshima Y., Kondoh H. (1994) The delta-crystallin enhancer-binding protein delta EF1 is a repressor of E2-box-mediated gene activation. Mol. Cell. Biol. 14: 5692-5700
31. Postigo A.A., Dean D.C. (1997) ZEB, a vertebrate homolog of Drosophila Zfh-1, is a negative regulator of muscle differentiation. EMBO J. 16: 3935-3943
32. Eger A., Aigner K., Sonderegger S., Dampier B., Oehler S., Schreiber M., Berx G., Cano A., Beug H., Foisner R. (2005) DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells. Oncogene 24: 2375-2385
33. Higashi Y., Moribe H., Takagi T., Sekido R., Kawakami K., Kikutani H., Kondoh H. (1997) Impairment of T cell development in deltaEF1 mutant mice. J. Exp. Med. 185: 1467-1479
34. Terraz C., Toman D., Delauche M., Ronco P., Rossert J. (2001) delta Ef1 binds to a far upstream sequence of the mouse pro-alpha 1(I) collagen gene and represses its expression in osteoblasts. J. Biol. Chem. 276: 37011-37019
35. Murray D., Precht P., Balakir R., Horton WE Jr. (2000) The transcription factor deltaEF1 is inversely expressed with type II collagen mRNA and can repress Col2a1 promoter activity in transfected chondrocytes. J. Biol. Chem. 275: 3610-3618
36. Sooy K., Demay M.B. (2002) Transcriptional repression of the rat osteocalcin gene by deltaEF1. Endocrinology 143: 3370-3375
37. Furusawa T., Moribe H., Kondoh H. and Higashi Y., Identification of CtBP1 and CtBP2 as corepressors of zinc finger-homeodomain factor deltaEF1. Mol. Cell. Biol. 19: 8581-8590, 1999
38. Chamberlain EM, Sanders MM (1999) Identification of the novel player δEF1 in estrogen transcriptional cascades. Mol. Cell. Biol. 19: 3600-3606
39. Lazarova D.L., Bordonaro M., Sartorelli A.C. (2001) Transcriptional regulation of the vitamin D(3) receptor gene by ZEB. Cell Growth Differ. 12: 319-326
40. Prashar Y., Weissman S.M. (1996) Analysis of differential gene expression by display of 3′ end restriction fragments of cDNAs. Proc. Natl. Acad. Sci. U.S.A. 93: 659-663
41. Lee M.H., Javed A., Kim H.J., Shin H.I., Gutierrez S., Choi J.Y., Rosen V., Stein J.L., Wijnen A.J., Stein G.S., Lian J.B., Ryoo H.M. (1999) Transient upregulation of CBFA1 in response to bone morphogenetic protein-2 and transforming growth factor beta1 in C2C12 myogenic cells coincides with suppression of the myogenic phenotype but is not sufficient for osteoblast differentiation. J. Cell. Biochem. 73: 114-125
42. Lee K.S., Kim H.J., Li Q.L., Chi X.Z., Ueta C., Komori T., Wozney J.M., Kim E.G., Cho J.Y., Ryoo H.M., Bae S.C. (2000) Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol. Cell. Biol. 20: 8783-8792
43. Nakashima K., Zhou X., Kunkel G., Zhang Z., Deng J.M., Behringer R.R., de Crombrugghe B. (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29
44. Shi Y., Massague J. (2003) Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113: 685-700
45. Bai X.C., Lu D., Bai J., Zheng H., Ke Z.Y., Li X.M., Luo S.Q. (2004) Oxidative stress inhibits osteoblastic differentiation of bone cells by ERK and NF-κB. Biochem. Biophys. Res. Commun. 314: 197-207
46. Lu X., Gilbert L., He X., Rubin J., Nanes M.S. (2006) Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NFκB pathways. J. Biol. Chem. 281: 6297-6306
47. Reddi A.H. (1998) Role of morphogenetic proteins in skeletal tissue engineering and regeneration. Nat. Biotechnol. 16: 247-252
48. Postigo A.A. (2003) Opposing functions of ZEB proteins in the regulation of the TGFbeta/BMP signaling pathway. EMBO J. 22: 2443-2452
49. Postigo A.A., Depp J.L., Taylor J.J., Kroll K.L. (2003) Regulation of Smad signaling through a differential recruitment of coactivators and corepressors by ZEB proteins. EMBO J. 22: 2453-2462
50. Turner J., Crossley M. (2001) The CtBP family: enigmatic and enzymatic transcriptional co-repressors. Bioessays. 23: 683-690
51. Chinnadurai G. (2002) CtBP, an unconventional transcriptional corepressor in development and oncogenesis. Mol. Cell 9: 213-224
52. Ikeda K., Halle J.P., Stelzer G., Meisterernst M., Kawakami K. (1998) Involvement of negative cofactor NC2 in active repression by zinc finger-homeodomain transcription factor AREB6. Mol. Cell. Biol. 18: 10-18
53. Ayse B.C., Jeffrey O.H., Phil G.C. (2005) Osx transcriptional regulation is mediated by additional pathways to BMP2/Smad signaling. J. Cell Biol. 95: 518-528
54. Jochum W., David J.P., Elliott C., Wutz A., Plenk H. Jr., Matsuo K., Wagner E.F. (2000) Increased bone formation and osteosclerosis in mice overexpressing the transcription factor Fra-1. Nat. Med. 6: 980-984
55. Sabatakos G., Sims N.A., Chen J., Aoki K., Kelz M., Amling M., Bouali Y., Mukhopadhyay K., Ford K., Nestler E., Baron R. (2000) Overexpression of DeltaFosB transcription factor(s) increases bone formation and inhibits adipogenesis. Nat. Med. 6: 985-990
56. Iotsova V., Caamano J., Loy J., Yang Y., Lewin A., Bravo R. (1997) Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3: 1285-1289
57. 3 and tumor necrosis factor-alpha in the rat osteocalcin gene. Endocrinology 134: 1113-1120